Xolair 150mg-IND (Omalizumab Vials) 150mg

Xolair 150mg-IND (omalizumab) is a prescription biologic used for allergic asthma and chronic urticaria. Store vials refrigerated between 2-8°C. This injectable therapy targets immunoglobulin E (IgE) to reduce allergic reactions.

Strength

150mg

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Novartis Pharma Stein AG

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Omalizumab is commonly prescribed to help control symptoms of moderate to severe allergic asthma in patients who are not adequately managed by inhaled corticosteroids. It is also used for chronic idiopathic urticaria (hives) in adults and adolescents who remain symptomatic despite antihistamine treatment. This medication works by binding to IgE, reducing the body's allergic response.

Side Effects

Many patients experience fewer asthma attacks or hives flare-ups after starting omalizumab therapy. Some report improved breathing and reduced need for rescue inhalers. Symptom relief may take several weeks to become noticeable. Individual responses vary based on condition and treatment duration.

Precautions & Warnings

Keep vials refrigerated at 2-8°C and protect from light. Do not freeze or shake the vial. Always check the solution for particles or discoloration before use. Discuss your full medical history with a healthcare provider, including allergies and current medications.

Avoid Interactions

No major drug interactions have been established, but caution is advised when combining with other biologics or immunosuppressants. Alcohol and certain foods do not typically interact with omalizumab. Always inform your doctor about all medications and supplements you are taking.

References

Frequently Asked Questions

Xolair 150mg (omalizumab) is used to treat moderate to severe allergic asthma and chronic idiopathic urticaria (hives) in patients who do not respond well to other treatments.

Xolair 150mg is given as an injection under the skin (subcutaneous) by a healthcare professional, typically every 2 to 4 weeks.

No, Xolair 150mg vials must be kept refrigerated between 2-8°C and protected from light. Do not freeze or shake the vial.

Common side effects may include injection site reactions, headache, and upper respiratory tract infections. Serious allergic reactions are rare but possible.

No, Xolair 150mg (omalizumab) is a monoclonal antibody, not a steroid. It works by targeting immunoglobulin E (IgE) to reduce allergic responses.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.